Tuesday, April 23, 2019

Treatment Plans And CBD Anxiety Wellbeing

By Betty West


When it comes to alternative and natural products, individuals need to be cautious as some are safer than others. For example, while a CBD anxiety wellbeing health plan can be a good option, there are other natural products which can cause more harm than good. As such, it is important to know whether any natural product, including CBD products have the potential to interact with OTC products or prescription medications.

CBD, originally discovered in the early 1940s, comes from the plant known as hemp or cannabis. CBD extract is one of several cannabinoids found in the plant. Whereas, CBDs account for upwards of forty percent of extract from the plant. To date, studies have proved CBD oil effective in treating epilepsy, movement disorders, anxiety and pain.

CBD oil can be ingested in different forms. These include vapor, smoke, drinks and edibles such as chocolate cover coffee beans, honey sticks, peanut better, cough drops and gummies. In addition, there are now CBD dog treats for treating dogs with anxiety or hyperactivity issues. Whereas, raw coffee beans can also be purchased with which to make CBD infused coffee.

There are basically two types of CBD oil, one which contains only CBD as the active ingredient with no THC or a full plant CBD dominant hemp extract, dried cannabis and capsules. While this is the case, there are only trace amounts of THC even in full plant hemp extract. Therefore, these products do not provoke the same high as marijuana or medical marijuana and associated products.

While the drug Epidiolex which contains CBD oil has received a green light for marketing from the United States FDA, there remains some confusion as to the full legality of CBD products. In addition, there can be minimal side effects depending on the length of use and potency of the product. While these can include a loss of appetite, diarrhea, fatigue, malaise, weakness and sleeping problems, these are minimal compared to side-effects associated with medications which contain opioids.

Presently, the FDA has labeled Epidiolex a Schedule V drug. Whereas, non-Epidiolex CBD still remains a Schedule I drug in the U. S. Regardless, there are outlets across America which are storing, shelving and selling these products on a daily basis. Whereas, the World Health Organization has refused to classify, schedule or regulate CBD products.

While there are few side effects compared to opioids and other narcotics, the potential of interactions with pharmaceuticals or over the counter drugs remain widely unknown. While this is the case, it is suspected that due to the potency of the extract, it could slow down the process of other medications. As far as dangerous interactions, at this point and time, none have been reported through research studies or use of CBD products.

As with medical marijuana and THC, the prescription forms of CBD extract are stronger than that of over the counter products. One such drug, Nabiximols combines THC and CBD in equal proportion. The drug, approved by Health Canada in 2005 was developed for the treatment of pain related to MS. Whereas, in 2007, the drug also became available to cancer patients as an ongoing treatment for pain and side-effects from chemotherapy and radiation, such as nausea.




About the Author:



0 comments:

Post a Comment

Share

Twitter Delicious Facebook Digg Stumbleupon Favorites More